EUVIMEDEUVIMED entdecken
Crossref

Insight Into the Degradation Pathways of an AAV9

Antonela Rodriguez, Supriya Jalimarada-Shivakumar, Ali Banazadeh, Sharmin Afroz, Amr Ali, Kangwen Deng, Lili Huang, Lionel Galibert, Rajeeva Singh, Chen Zhou

Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.xphs.2024.05.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Antonela Rodriguez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biologics Drug Product Development, AbbVie Bioresearch Center, Worcester, MA 01605, United States. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: AbbVie Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of recombinant adeno-associated virus (AAV) vectors is a popular choice for in vivo gene therapy, with hundreds of ongoing clinical trials targeting various genetic diseases. However, due to limited material availability and the complexity of AAV structure, there is a critical lack of comprehensive studies on AAV degradation pathways. In this study, we intended to elucidate the degradation pathways for a model AAV9 with GFP as the transgene under relevant stressed conditions. We assessed a diverse set of critical quality attributes and examined the overall impact of various stresses on transgene expression. This assessment revealed various degradation mechanisms of AAV9 and demonstrated the potential risk of a base formulation in causing AAV9 instability and potency loss under thermal stress at 25 and 40 °C while maintaining stability under freeze-thaw stress, interfacial stress due to membrane filtration, and short-term storage of up to 4 weeks at 5 °C.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsHumansGreen Fluorescent ProteinsTransgenesGenetic TherapyHEK293 Cells

Stichwörter der Autor:innen

AAVDegradationGene therapy

Substanzen

Green Fluorescent Proteins

Autor:innen und Institutionen

  • Biologics Drug Product Development, AbbVie Bioresearch Center, Worcester, MA 01605, United States.
  • Biotherapeutics and Genetic Medicine, AbbVie Bioresearch Center, Worcester, MA 01605, United States.
  • Analytical Development, Science & Technology Biologics, AbbVie Bioresearch Center, Worcester, MA 01605, United States.
  • Biologics Drug Product Development, AbbVie Bioresearch Center, Worcester, MA 01605, United States. Electronic address: chen.zhou@abbvie.com.

Förderung

  • AbbVie Inc

Zitieren

APA

Rodriguez, A., Jalimarada-Shivakumar, S., Banazadeh, A., Afroz, S., Ali, A., Deng, K., Huang, L., Galibert, L., Singh, R., & Zhou, C. (2024). Insight Into the Degradation Pathways of an AAV9. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2024.05.034

Vancouver

Rodriguez A, Jalimarada-Shivakumar S, Banazadeh A, Afroz S, Ali A, Deng K, et al. Insight Into the Degradation Pathways of an AAV9. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2024.05.034

BibTeX
@article{Rodriguez2024,
  author = {Rodriguez, Antonela and Jalimarada-Shivakumar, Supriya and Banazadeh, Ali and Afroz, Sharmin and Ali, Amr and Deng, Kangwen and Huang, Lili and Galibert, Lionel and Singh, Rajeeva and Zhou, Chen},
  title = {Insight Into the Degradation Pathways of an AAV9},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.xphs.2024.05.034}
}
Kostenlos starten →